ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.645,58
-0,08%
S&P 500
5.048,42
-0,46%
US Dollar vs BRL
5,1602
0,00%
Bitcoin
64.533,55
0,08%
Brent Oil
88,115
-0,04%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) Notícias

AMGN Amgen Inc

267,60
-5,41 (-1,98%)
25 Abr 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Amgen Inc AMGN NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
-5,41 -1,98% 267,60 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
273,45 267,24 274,35 269,38 273,01
mais cotações »

Notícias Recentes

Data Hora Fonte Título
16/04/202418:26PRNUSAMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
09/03/202414:20PRNUSAMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD..
06/03/202418:00PRNUSAMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
29/02/202418:00PRNUSAMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE..
26/02/202411:00PRNUSAMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN..
19/02/202418:00PRNUSAMGEN TO HOST CONFERENCE CALL ON RARE DISEASE
09/02/202418:00PRNUSAMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE..
07/02/202407:49IHMARKETNEWSMoody’s Downgrades NYCB to Junk Status, Ford Declares..
06/02/202419:05IHMARKETNEWSU.S. Stocks Finish Choppy Trading Day Modestly Higher
06/02/202418:01PRNUSAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL..
06/02/202408:27IHMARKETNEWSUS Index Futures Mixed, Oil Prices Edge Higher
02/02/202418:25IHMARKETNEWSU.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon..
01/02/202418:00PRNUSAMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR..
29/01/202407:00PRNUSdeCODE genetics: A sequence variant that increases risk of..
17/01/202408:33IHMARKETNEWSWall Street Highlights: Tesla Cuts Prices in Germany,..
10/01/202412:12DJNXeris Biopharma Shares Climb 12% on Amgen License Agreement
10/01/202410:53DJNXeris Biopharma Reaches License Agreement With Amgen On..
10/01/202410:45IHNWGLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
03/01/202418:00PRNUSAMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE..
02/01/202413:42DJNAmgen On Pace for Record High Close -- Data Talk
26/12/202311:00PRNUSAMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS®..
14/12/202311:53DJNAmgen Names James Bradner Chief Scientific Officer
14/12/202311:00PRNUSAMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE..
14/12/202307:00PRNUSAMGEN TO SPONSOR THE IRISH OPEN
13/12/202318:40DJNAmgen Gets FDA Priority Review For Lung Cancer Treatment
13/12/202318:00PRNUSFDA Grants Priority Review to Amgen's Tarlatamab Application..
13/12/202308:30IHMARKETNEWSCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend..
12/12/202318:41DJNAmgen Raises Dividend 5.6% To $2.25 A Share
12/12/202318:00PRNUSAMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO..
08/12/202311:00PRNUSAMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
22/11/202318:00PRNUSAMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE
10/11/202311:00PRNUSAMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
07/11/202318:05PRNUSAMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT..
07/11/202318:00PRNUSAMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN..
06/11/202313:00PRNCAEpidemiology and Genetics of Clonal Hematopoiesis, a..
02/11/202309:00PRNUSAMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES..
01/11/202310:00PRNUSAMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED..
01/11/202309:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
31/10/202320:35DJNAmgen Gets FDA Approval for Inflammatory Diseases Treatment
31/10/202311:43DJNAmgen on Pace for Largest Percent Decrease Since September..
31/10/202311:36DJNTrending: Amgen's Quarterly Profits Top Street Views
31/10/202308:38DJNAmgen Lifts FY23 Guidance After 3Q Adjusted Profit Tops..
31/10/202308:30DJNAmgen 3Q Profit Sinks On Discontinued Development Charge
31/10/202308:24IHMARKETNEWSTuesday’s Wall Street Highlights: Pinterest, BP, Wolfspeed,..
31/10/202308:00PRNUSAMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
25/10/202317:00PRNUSAMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL..
24/10/202317:00PRNUSAMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND
24/10/202314:20DJNAmgen to Lay Off 350 U.S. Employees of Horizon Therapeutics
22/10/202311:30PRNUSAMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX®..
20/10/202309:00PRNUSAMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER

Seu Histórico Recente

NASDAQ
AMGN
Amgen
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados